Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland
2009-013647-10Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in amphetamine dependence comparing Extended-release naltrexone (Vivitrol) with Placebo (2 arms). Primary endpoint: Proportion of amphetamine-negative urine samples during weeks 1-24. Started Oct 2009; status: completed.
02
Drugs
naltrexone
03
Conditions
amphetamine dependence
Beyond the preview
Go deeper on 2009-013647-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013647-10.